Terray raised $120 million to advance AI-driven drug discovery
Longevity Technology - 21-Oct-2024Their partnership with Calico focuses on age-related disease treatments
Join the club for FREE to access the whole archive and other member benefits.
Biotechnology company accelerating AI-driven drug discovery
Terray Therapeutics is a biotechnology company operating at the convergence of AI, biology, medicinal chemistry, automation, and nanotechnology to propel drug discovery into the information age. Terray’s proprietary integrated computational and experimental platforms generate massively scaled, powerfully agnostic chemical data that are purpose-built to power computational learning and reveal new interactions. This foundation is building an iterative, flexible chemistry engine that delivers more precise therapies to patients faster than ever before.
The first step to powering an engine is to add the right fuel. We’re generating chemical data purpose-built for drug discovery in the information age.
A closed-loop system generates precise chemical datasets at unrivaled scale that work seamlessly with AI to systematically map biochemical interactions between small molecules and causes of disease. With unparalleled resolution, we’re finally able to meet the challenge of drug discovery with the power of both scale experimentation and modern computation, deriving insights that lead to new drugs for patients in need.
Visit website: https://terraytx.com/
Details last updated 16-Oct-2022
Their partnership with Calico focuses on age-related disease treatments
Terray’s novel microarray technology, combines wet lab and computer-driven drug development